|
|
||||||||
Baker Medical Research Institute, Melbourne, Victoria 8008, Australia
The effect of chronic activation or inhibition of central ANG II receptors on cardiac baroreflex function in conscious normotensive rabbits was examined. Animals received a fourth ventricular (4V) infusion of ANG II (30 and 100 ng/h), losartan (3 and 30 µg/h), or Ringer solution (2 µl/h) for 2 wk. After 1 and 2 wk, ANG II (100 ng/h) decreased cardiac baroreflex gain by 20 and 37%, respectively (P = 0.015), whereas losartan (30 µg/h) increased baroreflex gain by 24 and 58%, respectively (P = 0.02). Within 1 wk of the end of the infusions, cardiac baroreflex gain had returned to control. Ringer solution or the lower doses of ANG II or losartan did not modify the cardiac baroreflex function. Blood pressure and heart rate were not altered by any treatment, nor was their variability affected. These data demonstrate a novel long-term modulation of cardiac baroreflexes by endogenous ANG II that is independent of blood pressure level.
blood pressure; angiotensin type 1 receptors; fourth ventricular administration; long-term infusion
This article has been cited by other articles:
![]() |
M. C. Laterza, L. D.N.J. de Matos, I. C. Trombetta, A. M.W. Braga, F. Roveda, M. J.N.N. Alves, E. M. Krieger, C. E. Negrao, and M. U.P.B. Rondon Exercise Training Restores Baroreflex Sensitivity in Never-Treated Hypertensive Patients Hypertension, June 1, 2007; 49(6): 1298 - 1306. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Paul, A. Poyan Mehr, and R. Kreutz Physiology of local Renin-Angiotensin systems. Physiol Rev, July 1, 2006; 86(3): 747 - 803. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Mousa, L. Gao, K. G. Cornish, and I. H. Zucker Effects of angiotensin II on autonomic components of nasopharyngeal stimulation in male conscious rabbits J Appl Physiol, May 1, 2005; 98(5): 1607 - 1611. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Xue, J. Pamidimukkala, and M. Hay Sex differences in the development of angiotensin II-induced hypertension in conscious mice Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2177 - H2184. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Gao, W. Wang, Y.-L. Li, H. D. Schultz, D. Liu, K. G. Cornish, and I. H. Zucker Sympathoexcitation by central ANG II: Roles for AT1 receptor upregulation and NAD(P)H oxidase in RVLM Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2271 - H2279. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sakai, M. W. Chapleau, S. Morimoto, M. D. Cassell, and C. D. Sigmund Differential modulation of baroreflex control of heart rate by neuron- vs. glia-derived angiotensin II Physiol Genomics, December 15, 2004; 20(1): 66 - 72. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Maliszewska-Scislo, T. J. Scislo, and N. F. Rossi Effect of blockade of endogenous angiotensin II on baroreflex function in conscious diabetic rats Am J Physiol Heart Circ Physiol, May 1, 2003; 284(5): H1601 - H1611. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. P. O'Hagan, K. A. Skogg, and J. B. Stevenson AT1 receptor block does not affect arterial baroreflex during pregnancy in rabbits Am J Physiol Heart Circ Physiol, May 1, 2001; 280(5): H1996 - H2005. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Baltatu, B. J. Janssen, G. Bricca, R. Plehm, J. Monti, D. Ganten, and M. Bader Alterations in Blood Pressure and Heart Rate Variability in Transgenic Rats With Low Brain Angiotensinogen Hypertension, February 1, 2001; 37(2): 408 - 413. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Morimoto, M. D. Cassell, T. G. Beltz, A. K. Johnson, R. L. Davisson, and C. D. Sigmund Elevated Blood Pressure in Transgenic Mice With Brain-Specific Expression of Human Angiotensinogen Driven by the Glial Fibrillary Acidic Protein Promoter Circ. Res., August 17, 2001; 89(4): 365 - 372. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |